Abstract

Hamamelis virginiana L. a rich source of both condensed and hydrolyzable tannins, utilized to treat dermatological disorders. Since no experimental and clinical data is available for its use as oral formulation in skin related disorders, the purpose of this study was to investigate the effects of Hamaforton™ (Hamamelis virginiana extract) metabolites on gene dysregulation induced by ultraviolet A radiation in cultured human dermal fibroblasts. A combination of in vivo and ex vivo experimental designs has been exploited in order to take into account the polyphenol metabolic transformation that occurs in humans. 12 healthy volunteers received either a capsule of Hamaforton™ or a placebo in a randomized, blinded crossover trial. After Hamaforton™ ingestion, the kinetic of appearance of galloyl derivatives was measured in plasma. Then, in the ex vivo experiment, the serum isolated after supplementation was used as a source of Hamaforton™ metabolites to enrich the culture medium of dermal fibroblasts exposed to ultraviolet A radiation. Three different gallic acid metabolites (4-O-methyl gallic acid, 4-O-methyl gallic acid sulphate and trimethyl gallic acid glucuronide) were identified in volunteer plasma. While, ultraviolet A irradiation of dermal fibroblasts affected the expression of extracellular matrix genes, the presence of Hamaforton™ metabolites in the culture media did not affect the expression of most of those genes. However, the activation of the expression of 10 different genes involved in repair processes for the maintenance of skin integrity, suggest that the metabolites can play a role in damage recovery. To our knowledge, this is the first study that demonstrates the bioavailability of Hamaforton™ phenolic compounds, and the effects of its metabolites on cultured dermal fibroblast response to ultraviolet A irradiation.

Highlights

  • Hamamelis virginiana L. known as witch hazel, a rich source of both condensed and hydrolyzable tannins, is a shrub that belongs to the Hamamelidaceae family

  • The maximum concentration reached after capsule ingestion was 0.18 ± 0.11 μg/ml plasma for 4-O-methyl gallic acid, 0.11 ± 0.07 μg/ml plasma for 4-O-methyl gallic acid sulphate and 0.01 ± 0.01 μg/ml for trimethyl gallic acid glucuronide

  • Phenolic bioavailability is mainly dependent on chemical phenolic structure but it can be influenced by the characteristics of the subject, (Teng and Chen, 2019)

Read more

Summary

Introduction

Hamamelis virginiana L. known as witch hazel, a rich source of both condensed and hydrolyzable tannins, is a shrub that belongs to the Hamamelidaceae family. Leaves, bark and twigs, commercially available as extracts, tinctures, distillates, creams and lotions, are utilized for dermatological disorders They are used for their astringent and antiphlogistic properties as anti-inflammatory agents for skin disorders, to promote healing and alleviate sunburn, skin or mucosal irritation, phlebitis, varicose veins, ulcers of varicose veins and haemorrhoids (Reuter et al, 2010). In vitro investigations evaluated the antitumoral, antioxidant and anti-inflammatory activity of witch hazel extracts (Lizárraga et al, 2008; Thring et al, 2009; Thring et al, 2011; Sánchez-Tena et al, 2012), while in vivo human approaches are limited to the study on the effects of topical treatments against ultraviolet radiation-induced erythema (Hughes-Formella et al, 2002). A preclinical model (Natella et al, 2014) of ex vivo cultured dermal fibroblast incubated with human sera after Hamamelis v. extract supplementation was used to study the effects of Hamamelis v. metabolites on cellular damage induced by ultraviolet radiation-A irradiation

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call